不完全川崎病的临床表现特点分析
Clinical Characteristics Analysis of Incomplete Kawasaki Disease
摘要: 川崎病(Kawasaki disease, KD)属于一种病因尚未完全阐明的急性自限性血管炎症,好发于5岁以下的儿童,最让人担心的是它会伤害冠状动脉。若患儿符合的典型主要临床表现不足4条,便可诊断为不完全川崎病(incomplete Kawasaki disease, IKD)。IKD在临床上的难点在于发热可能作为唯一突出表现,结膜充血、皮疹、肢端脱屑、颈部淋巴结肿大等主要体征要么缺位,要么先后出现且表现不典型,导致其极易与麻疹、腺病毒感染或幼年特发性关节炎混淆。更为严重的是,IKD具有较高的冠状动脉损伤风险,漏诊后可能遗留心脏后遗症。因此,系统梳理IKD的临床特征具有明确的必要性和紧迫性。本综述围绕上述问题,回顾分析了近年来有关IKD的流行病学特点、临床表现、实验室检查、影像学改变及治疗反应,旨在提升儿科医生对该病的识别能力,减少误诊漏诊,改善患儿预后。
Abstract: Kawasaki disease (KD) is an acute self-limiting vasculitis of unknown etiology, predominantly affecting children under 5 years of age, with coronary artery injury being its most serious complication. When a patient presents with fewer than four of the typical major clinical manifestations, the condition is diagnosed as incomplete Kawasaki disease (IKD). The clinical challenge of IKD lies in the fact that fever may be the sole prominent feature, while other cardinal signs, such as conjunctival injection, rash, extremity desquamation, and cervical lymphadenopathy, are either absent or appear sequentially with atypical presentations. This often leads to misdiagnosis with measles, adenovirus infection, or juvenile idiopathic arthritis. More critically, IKD carries a high risk of coronary artery damage, and delayed diagnosis may result in long-term cardiac sequelae. Therefore, a systematic review of the clinical characteristics of IKD is both necessary and urgent. This review summarizes recent findings on the epidemiological features, clinical manifestations, laboratory tests, imaging changes, and treatment response of IKD, aiming to enhance pediatricians’ ability to recognize the disease, reduce misdiagnosis and delayed diagnosis, and improve patient outcomes.
文章引用:邓于杰, 刘斌. 不完全川崎病的临床表现特点分析[J]. 临床医学进展, 2026, 16(6): 1550-1559. https://doi.org/10.12677/acm.2026.1662369

参考文献

[1] 泮思林, 刘芳, 罗刚. 日本《川崎病诊断指南第6次修订版》要点解读[J]. 中国实用儿科杂志, 2020, 35(11): 846-849.
[2] 张乾忠. 不典型川崎病的临床表现和诊断[J]. 中国实用儿科杂志, 2006(10): 728-730.
[3] 聂颖, 徐辉甫, 陈长见, 等. 儿童不完全川崎病的临床特点分析[J]. 中国全科医学, 2019, 22(24): 2970-2974.
[4] 王秀英, 董海云, 许毅, 等. 88例不完全川崎病的临床特点及随访分析[J]. 中国当代儿科杂志, 2011, 13(1): 57-59.
[5] 张伟, 王莉, 朱生东, 等. 2014~2018年我院不完全川崎病诊断及临床特点分析[J]. 医学信息, 2021, 34(2): 149-151.
[6] 暴雨. 内蒙古中西部地区不完全川崎病的临床特点及预警指标探讨[D]: [硕士学位论文]. 呼和浩特: 内蒙古医科大学, 2022.
[7] 张丹凤, 钟家蓉, 王丹. 完全川崎病和不完全川崎病冠脉病变对比研究[J]. 临床儿科杂志, 2018, 36(1): 14-18.
[8] Sudo, D., Monobe, Y., Yashiro, M., Mieno, M.N., Uehara, R., Tsuchiya, K., et al. (2012) Coronary Artery Lesions of Incomplete Kawasaki Disease: A Nationwide Survey in Japan. European Journal of Pediatrics, 171, 651-656. [Google Scholar] [CrossRef] [PubMed]
[9] 李丹. 不完全型川崎病的临床特点分析[J]. 中国民康医学, 2014, 26(17): 28+31.
[10] 许慧, 周彬, 王彦波, 等. 不完全型川崎病患儿的临床特点分析[J]. 医学研究杂志, 2023, 52(10): 131-135.
[11] 梁莹, 李柏, 廖素雯. 35例不完全川崎病患儿临床特点分析及临床治疗效果[J]. 临床合理用药杂志, 2018, 11(15): 118-119.
[12] 赵醴, 钱娟, 王莹, 等. 非典型川崎病的诊断(附29例分析) [J]. 中国当代儿科杂志, 2004(5): 429-431.
[13] 张小平, 杨蕊华, 王俊英, 等. 婴儿不完全川崎病临床特点回顾性分析[J]. 山西医药杂志, 2021, 50(21): 3033-3036.
[14] 熊寿贵, 宋玫, 周传恩. 不完全川崎病13例临床特点分析[J]. 中国中西医结合儿科学, 2013, 5(3): 255-257.
[15] 李天颂, 林炎浩, 刁仕明. 儿童不完全川崎病与完全川崎病临床特点对比分析[J]. 基层医学论坛, 2022, 26(8): 148-150.
[16] 耿玲玲, 苗峰, 李小青. 不完全川崎病合并冠状动脉瘤的临床特点分析[J]. 中国全科医学, 2018, 21(30): 3761-3764.
[17] 彭昌, 罗月静, 幸黔鲁, 等. 儿童不完全川崎病的临床特点分析[J]. 中国当代儿科杂志, 2016, 18(11): 1111-1114.
[18] 陈颖. 不完全川崎病(IKD)的临床特点及早期实验室指标变化[J]. 中国中医急症, 2014, 24(8): 1558-1559.
[19] 冯冰瑜, 刘凯, 孙娜, 等. 川崎病与不完全性川崎病临床特点的比较分析: 多中心观察性研究[J]. 新医学, 2014, 45(2): 127-130.
[20] 杨显贵. 不完全川崎病32例临床特点分析[J]. 中国医学文摘(儿科学), 2006(6): 379-380.
[21] 刘波, 张久贵, 蒋鸿萍, 等. 不完全川崎病(IKD)患儿的临床特点分析[J]. 当代医学, 2020, 26(3): 52-54.
[22] 刘丁, 杨方. 典型川崎病与不完全川崎病的临床特点单中心比较分析[J]. 临床荟萃, 2018, 33(3): 236-239.
[23] 罗莉娜. 小儿不完全川崎病36例的临床分析[J]. 广西医学, 2012, 34(8): 1111-1112.
[24] 陈波, 邹外一, 王峰, 等. 小儿不完全川崎病16例临床分析[J]. 实用医学杂志, 2008(13): 2282-2284.
[25] 李晓冰, 何德根, 彭通, 等. 完全性川崎病与不完全性川崎病患儿临床特点比较[J]. 中国妇幼健康研究, 2018, 29(5): 618-621.
[26] 刘晓华. 不完全川崎病35例临床特点分析[J]. 中国医学文摘(儿科学), 2008(5): 376-377.
[27] Ko, K.O. and Cheon, E.J. (2024) Anterior Uveitis as an Early Diagnostic Marker in Incomplete Kawasaki Disease. BMC Pediatrics, 24, Article No. 644. [Google Scholar] [CrossRef] [PubMed]
[28] 商晓式, 李建业. 完全川崎病和不完全川崎病的临床特点差异及丙种球蛋白联合阿司匹林的干预效果分析[J]. 中国免疫学杂志, 2025, 41(4): 967-971.
[29] Yang, Z., Pan, B., Liu, J., Wang, H. and Tian, J. (2025) A New Prediction Diagnosis Model of Incomplete Kawasaki Disease Based on Data Mining with Big Data. Pediatric Discovery, 3, e2516. [Google Scholar] [CrossRef
[30] Choi, J.E., Kwak, Y., Huh, J.W., Yoo, E., Ryu, K., Sohn, S., et al. (2018) Differentiation between Incomplete Kawasaki Disease and Secondary Hemophagocytic Lymphohistiocytosis Following Kawasaki Disease Using N-Terminal Pro-Brain Natriuretic Peptide. Korean Journal of Pediatrics, 61, 167-173. [Google Scholar] [CrossRef] [PubMed]
[31] Novais, C., Fortunato, F., Bicho, A. and Preto, L. (2016) Bacillus Calmette-Guérin Reactivation as a Sign of Incomplete Kawasaki Disease. BMJ Case Reports, 2016, bcr2015213875. [Google Scholar] [CrossRef] [PubMed]
[32] Yu, X., Yang, M.C., Jindal, A.K., et al. (2023) A Collaborative Study for Incomplete Kawasaki Disease in Asia. International Journal of Rheumatic Diseases, 26, 2589-2591. [Google Scholar] [CrossRef] [PubMed]
[33] Wang, L., Zeng, X. and Chen, B. (2023) Clinical Manifestations and Risk Factors of Coronary Artery Lesions in Children with Kawasaki Disease. Medicine, 102, e34939. [Google Scholar] [CrossRef] [PubMed]
[34] Cai, W.J. and Ding, S.G. (2022) Retrospective Analysis of Clinical Characteristics and Related Influencing Factors of Kawasaki Disease. Medicine, 101, e32430. [Google Scholar] [CrossRef] [PubMed]
[35] 李琪, 贺湘英, 肖群文, 等. 不完全川崎病的早期诊治[J]. 昆明医学院学报, 2008(2): 159-161.
[36] Sakina, S., Owais, S.S., Khan, E.A. and Sheikh, A.M. (2020) Kawasaki Disease: Clinico-Laboratory Spectrum and Outcome in a Cohort of Children Treated at a Tertiary Care Hospital in Islamabad, Pakistan. Pakistan Journal of Medical Sciences, 36, 260-264. [Google Scholar] [CrossRef] [PubMed]
[37] Bressieux-Degueldre, S., Gradoux, E., Di Bernardo, S. and Sekarski, N. (2023) Complete and Incomplete Kawasaki Disease: Clinical Differences and Coronary Artery Outcome from a National Prospective Surveillance Study in Switzerland. Frontiers in Pediatrics, 11, Article 1137841. [Google Scholar] [CrossRef] [PubMed]
[38] Lin, S., He, Y., He, L., Liu, Y., Wang, F., Xiong, Z., et al. (2026) Randomized Trial of Adjunctive Prednisolone for Kawasaki Disease. New England Journal of Medicine, 394, 1480-1490. [Google Scholar] [CrossRef
[39] Shenoy, B. and Arun, B.C. (2022) Retrospective Cohort Study of Clinical Profile and IVIg Resistance in Children with Incomplete Kawasaki Disease in a Tertiary Care Center. Pediatric Infectious Disease, 4, 83-85. [Google Scholar] [CrossRef
[40] Yu, J.J. (2012) Diagnosis of Incomplete Kawasaki Disease. Korean Journal of Pediatrics, 55, 83-87. [Google Scholar] [CrossRef] [PubMed]
[41] La Torre, F., Meliota, G., Civino, A., Campanozzi, A., Cecinati, V., Rosati, E., et al. (2025) Advancing Multidisciplinary Management of Pediatric Hyperinflammatory Disorders. Frontiers in Pediatrics, 13, Article 1553861. [Google Scholar] [CrossRef] [PubMed]
[42] Boyarchuk, O., Zaleshchuk, M.V., Zaremba, R., et al. (2026) Kawasaki Disease vs. MIS-C in a Child with Congenital Coronary Artery Anomaly: A Case Report. Frontiers in Pediatrics, 14, Article 1768080. [Google Scholar] [CrossRef
[43] Fan, L.K., Bai, S., Du, C., Bass, M., Jones, K., Sherry, W., et al. (2023) Distinguishing Incomplete Kawasaki and Non-Severe Multisystem Inflammatory Syndrome in Children. Hospital Pediatrics, 13, e280-e284. [Google Scholar] [CrossRef] [PubMed]